Clinical Trials Browser

INDUSTRY × Expanded_access × entrectinib × Clear all

NCT03066661 2019-04-26

Expanded Access to Entrectinib for Cancers With NTRK1/2/3, ROS1, or ALK Gene Fusions

No longer available

Cancers With NTRK, ROS1, or ALK Gene Fusions